Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Tizona Therapeutics Presents Clinical Translational Evidence of Dual Innate and Adaptive Immune Activation with TTX-080, a First-in-Class HLA-G Antagonist, in Patients with Advanced Solid Tumors at SI
-
Financial calendar 2026
-
Nokia Corporation - Managers' transactions (Heard)
-
Sampo plc: Managers’ Transactions (Witschard)
-
Sampo plc: Managers’ Transactions (Stange)
-
Sampo plc: Managers’ Transactions (Rauramo)
-
Sampo plc: Managers’ Transactions (Langan)
-
Changes in Nokia Corporation's own shares
-
Sampo plc: Managers’ Transactions (Mella)
-
Sampo plc: Managers’ Transactions (Murto)
-
LITGRID AB 2025 9 months performance results
-
Sampo plc: Managers’ Transactions (Mäkinen)
-
ANNOUNCEMENT OF INTENTION TO MAKE A VOLUNTARY TAKEOVER BID TO ACQUIRE THE SHARES OF AKTSIASELTS EKSPRESS GRUPP
-
Nouscom Presents New Positive Phase 1/2b data of NOUS-209 at SITC 2025, Supporting Plans to Initiate Registration-Enabling Study for Cancer Interception in Lynch Syndrome Carriers
-
American Battery Technology Company Announces First Quarter Fiscal 2026 Financial Results
-
Neurogastrx Announces NG101 Phase 2 Clinical Study Demonstrating Significant Reductions in Nausea and Vomiting Induced by GLP-1 Receptor Agonist Semaglutide
-
Ipsen to present two late-breaking sessions at AASLD on new PBC data supporting IQIRVO®’s long-term efficacy, safety and mechanistic insights in fatigue
-
Today's Marketplace discusses state of M&A with Creighton University’s Tirimba Obonyo and Moelis’s Mark Henkels
-
Today's Marketplace discusses state of M&A with Creighton University’s Tirimba Obonyo and Moelis’s Mark Henkels
-
EZI @ EICMA 2025: Redefining Electric Light Mobility with Ai-Native EM05
-
Next Hydrogen Announces $20 to $30M Equity Private Placement led by Smoothwater Capital Corporation
-
REPEAT – Dorel Industries Will Hold a Conference Call to Discuss Its Third Quarter Results
-
Marimaca Regretfully Announces the Passing of Colin Kinley
-
New Pooled 3-Year Analysis Confirms Sustained, Clinically Meaningful Improvements in Renal Function for TransCon® PTH (Palopegteriparatide)-Treated Adults with Hypoparathyroidism
-
Star Equity Holdings to Release Third Quarter 2025 Financial Results on November 13
-
Bath & Body Works Declares Cash Dividend
-
Greenstone Provides Update on Holdings of Highland Copper Company Inc.
-
Bosuer Electrifies EICMA 2025 with Strategic Debut of Its High-Performance Off-Road Matrix
-
Biotricity to Host Fiscal 2026 Second Quarter Financial Results and Business Update Call on November 14th
-
ODYSIGHT.AI ANNOUNCES COMMERCIAL PURCHASE ORDER FOR 200 INDUSTRIAL PREDICTIVE MONITORING SYSTEMS FOR ELEVATORS
-
NRSInsights’ October 2025 Retail Same-Store Sales Report
-
Champion Safe Celebrates Hyatt Coin Shop for 30% Year-Over-Year Growth in the Southeast
-
Navitas Announces Private Placement of Common Stock for Proceeds of $100 Million
-
HUHUTECH’s U.S. Subsidiary Secures First Order Worth $3.0 Million, Marking a Breakthrough Following Its Nasdaq IPO
-
Lianhe Sowell International Group Ltd Announces Approval of Dual-Class Share Structure by Shareholders
-
WKSP Invites You to Join Its Third Quarter 2025 Earnings Conference Call
-
Wave Life Sciences to Present at Upcoming Investor Conferences
-
IPDN Welcomes His Highness Shaikh Ali Sultan Al Nuaimi of the UAE Royal Family as Independent Director
-
Form 8.3 - Qualcomm Incorporated
-
IES Holdings to Acquire Gulf Island Fabrication
-
ALX Oncology Reports Third Quarter 2025 Financial Results and Provides Corporate Update
-
Legacy Housing Announces Agreement to Purchase Assets of AmeriCasa Solutions, LLC and Addition of New Senior Management
-
Altimmune Presents AI-Based Analysis of Liver Fibrosis Reduction from IMPACT Phase 2b Trial of Pemvidutide in MASH in Late-breaking Poster at AASLD The Liver Meeting® 2025
-
IMUNON R&D Day: Opportunity to Hear Clinical Trial Investigators Discuss Significant Potential of IMNN-001 to Redefine Ovarian Cancer Treatment
-
IMUNON R&D Day: Opportunity to Hear Clinical Trial Investigators Discuss Significant Potential of IMNN-001 to Redefine Ovarian Cancer Treatment
-
Treace Announces Participation in Two Upcoming Investor Conferences
-
PlainsCapital Bank Recognized for Strong Support of North Texas Food Bank through Truck Sponsorship
-
Celldex to Present at Upcoming Investor Conferences
-
Conduent Reports Third Quarter 2025 Financial Results
-
Karbon-X Expands Blue Carbon Leadership with New Restoration Project in Guinea
